A bioinspired omniphobic surface coating on medical devices prevents thrombosis and biofouling

Nature Biotechnology

Volumn 32, Issue 11, 2014, Pages 1134-1140

  Leslie, Daniel C ^a,b,c,d   Waterhouse, Anna ^a,c,d   Berthet, Julia B ^a,c,d   Valentin, Thomas M ^a,c   Watters, Alexander L ^a,c   Jain, Abhishek ^a,c,d   Kim, Philseok ^a,b   Hatton, Benjamin D ^a,b,f   Nedder, Arthur ^d   Donovan, Kathryn ^d   Super, Elana H ^a   Howell, Caitlin ^a,b   Johnson, Christopher P ^a,b   Vu, Thy L ^a,b   Bolgen, Dana E ^a   Rifai, Sami ^a   Hansen, Anne R ^c,d   Aizenberg, Michael ^a   Super, Michael ^a,c,d   Aizenberg, Joanna ^a,b,e   Ingber, Donald E ^a,b,c,d   more..

^a HARVARD UNIVERSITY   (United States)

^b HARVARD UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e HARVARD UNIVERSITY   (United States)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOFILMS; BIOFOULING; BIOMEDICAL EQUIPMENT; BLOOD; CATHETERS; DISEASES; LIQUID FILMS; TUBING;

ANTI-COAGULATION; ARTERIOVENOUS SHUNT; BIOFILM FORMATION; EXTRACORPOREAL CIRCUITS; PERFLUOROCARBONS; PLATELET ADHESION; SURFACE COATINGS; THIN LIQUID FILM;

COATINGS;

FIBRIN; FLUOROCARBON; MOLECULAR LAYER; BIOCOMPATIBLE COATED MATERIAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOVENOUS SHUNT; ARTICLE; BIOFILM; BIOFOULING; BLOOD FLOW; CATHETER; CONTROLLED STUDY; FEMALE; FILM; IN VITRO STUDY; LIQUID; MATERIAL COATING; NONHUMAN; PRIORITY JOURNAL; SURFACE PROPERTY; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOSIS; ANIMAL; DEVICES; DRUG EFFECTS; HUMAN; MICROBIOLOGY; PIG; PREVENTION AND CONTROL;

ANIMALS; BIOFILMS; BIOFOULING; CATHETERS; COATED MATERIALS, BIOCOMPATIBLE; EQUIPMENT AND SUPPLIES; HUMANS; SURFACE PROPERTIES; SWINE; THROMBOSIS;

EID: 84983130316     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.3020     Document Type: Article

References (45)

1. McCarthy, P.M. & Smith, W.A. Mechanical circulatory support-a long and winding road. Science 295, 998-999 (2002).
2. Shen, J.I., Mitani, A.A., Chang, T.I. & Winkelmayer, W.C. Use and safety of heparin-free maintenance hemodialysis in the USA. Nephrol. Dial. Transplant. 28, 1589-1602 (2013).
3. von Segesser, L.K. et al. Risk and benefit of low systemic heparinization during open heart operations. Ann. Thorac. Surg. 58, 391-398 (1994).
4. Conn, G. et al. Is there an alternative to systemic anticoagulation, as related to interventional biomedical devices? Expert Rev. Med. Devices 3, 245-261 (2006).
5. Werner, C., Maitz, M.F. & Sperling, C. Current strategies towards hemocompatible coatings. J. Mater. Chem. 17, 3376-3384 (2007).
6. Cronin, R.E. & Reilly, R.F. Unfractionated heparin for hemodialysis: still the best option. Semin. Dial. 23, 510-515 (2010).
7. Finkel, K.W. & Podoll, A.S. Complications of continuous renal replacement therapy. Semin. Dial. 22, 155-159 (2009).
8. Shepherd, G., Mohorn, P., Yacoub, K. & May, D.W. Adverse drug reaction deaths reported in United States vital statistics, 1999-2006. Ann. Pharmacother. 46, 169-175 (2012).
9. Peppas, N. & Langer, R. New challenges in biomaterials. Science 263, 1715-1720 (1994).
10. Larm, O., Larsson, R. & Olsson, P. A new non-thrombogenic surface prepared by selective covalent binging of heparin via a modified reducing terminal residue. Biomater. Med. Devices Artif. Organs 11, 161-173 (1983).
11. Bannan, S. et al. Low heparinization with heparin-bonded bypass circuits: is it a safe strategy? Ann. Thorac. Surg. 63, 663-668 (1997).
12. Lobato, R.L. et al. Anticoagulation management during cardiopulmonary bypass: A survey of 54 North American institutions. J. Thorac. Cardiovasc. Surg. 139, 1665-1666 (2010).
13. Thiara, A.S. et al. Comparable biocompatibility of Phisio-and Bioline-coated cardiopulmonary bypass circuits indicated by the inflammatory response. Perfusion 25, 9-16 (2010).
14. Palanzo, D.A. et al. Effect of Carmeda® BioActive Surface coating versus Trillium™ Biopassive Surface coating of the oxygenator on circulating platelet count drop during cardiopulmonary bypass. Perfusion 16, 279-283 (2001).
15. Suhara, H. et al. Efficacy of a new coating material, PMEA, for cardiopulmonary bypass circuits in a porcine model. Ann. Thorac. Surg. 71, 1603-1608 (2001).
16. Smith, R.S. et al. Vascular catheters with a nonleaching poly-sulfobetaine surface modification reduce thrombus formation and microbial attachment. Sci. Transl. Med. 4, 153ra132 (2012).
17. Kutay, V. et al. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits. J. Card. Surg. 21, 572-577 (2006).
18. Reser, D. et al. Retrospective analysis of outcome data with regards to the use of Phisio®-, Bioline®-or Softline®-coated cardiopulmonary bypass circuits in cardiac surgery. Perfusion 27, 530-534 (2012).
19. Bohn, H.F. & Federle, W. Insect aquaplaning: Nepenthes pitcher plants capture prey with the peristome, a fully wettable water-lubricated anisotropic surface. Proc. Natl. Acad. Sci. USA 101, 14138-14143 (2004).
20. Wong, T.-S. et al. Bioinspired self-repairing slippery surfaces with pressure-stable omniphobicity. Nature 477, 443-447 (2011).
21. Clark, L. Jr. & Gollan, F. Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science 152, 1755-1756 (1966).
22. Clark, L.C. Jr. et al. Perfluorocarbons having a short dwell time in the liver. Science 181, 680-682 (1973).
23. Moss Vision Incorporated EC Certificate 3878-2007-CE-NOR 7.0. 〈http://www.mossvision.co.uk/dev/certificates/CE.pdf〉 Originally Issued: 2007 (2012).
24. Castro, C.I. & Briceno, J.C. Perfluorocarbon-based oxygen carriers: review of products and trials. Artif. Organs 34, 622-634 (2010).
25. Kim, P., Kreder, M.J., Alvarenga, J. & Aizenberg, J. Hierarchical or not? Effect of the length scale and hierarchy of the surface roughness on omniphobicity of lubricant-infused substrates. Nano Lett. 13, 1793-1799 (2013).
26. Vogel, N. et al. Transparency and damage tolerance of patternable omniphobic lubricated surfaces based on inverse colloidal monolayers. Nat. Commun. 4, 2167 (2013).
27. Stark, A.Y. et al. Surface wettability plays a significant role in gecko adhesion underwater. Proc. Natl. Acad. Sci. USA 110, 6340-6345 (2013).
28. Nilsson, J. et al. A randomized study of coronary artery bypass surgery performed with the Resting Heart™ System utilizing a low vs a standard dosage of heparin. Interact. Cardiovasc. Thorac. Surg. 15, 834-839 (2012).
29. Gould, S.A. et al. Fluosol-DA as a red-cell substitute in acute anemia. N. Engl. J. Med. 314, 1653-1656 (1986).
30. Epstein, A.K. et al. Liquid-infused structured surfaces with exceptional anti-biofouling performance. Proc. Natl. Acad. Sci. USA 109, 13182-13187 (2012).
31. Tevaearai, H.T. et al. Trillium coating of cardiopulmonary bypass circuits improves biocompatibility. Int. J. Artif. Organs 22, 629-634 (1999).
32. Nilsson, L. et al. Heparin-coated equipment reduces complement activation during cardiopulmonary bypass in the pig. Artif. Organs 14, 46-48 (1990).
33. Hartmann, R.C. & Conley, C.L. Studies on the initiation of blood coagulation. III. The clotting properties of canine platelet-free plasma. J. Clin. Invest. 31, 685-691 (1952).
34. Amarnath, L.P., Srinivas, A. & Ramamurthi, A. In vitro hemocompatibility testing of UV-modified hyaluronan hydrogels. Biomaterials 27, 1416-1424 (2006).
35. Liu, F. & Grainger, D.W. in Comprehensive Biomaterials (ed. Ducheyne, P.) (Elsevier Science, Oxford, UK, 2011).
36. Toes, G.J. et al. Superhydrophobic modification fails to improve the performance of small diameter expanded polytetrafluoroethylene vascular grafts. Biomaterials 23, 255-262 (2002).
37. Canaud, B. et al. Pathochemical toxicity of perfluorocarbon-5070, a liquid test performance fluid previously used in dialyzer manufacturing, confirmed in animal experiment. J. Am. Soc. Nephrol. 16, 1819-1823 (2005).
38. Strobel, M., Lyons, C.S. & Mittal, K. Plasma Surface Modification of Polymers: Relevance to Adhesion. edn. 1. (VSP, Leiden, the Netherlands, 1994).
39. Schröder, K. et al. Plasma-induced surface functionalization of polymeric biomaterials in ammonia plasma. Contrib. Plasma Phys. 41, 562-572 (2001).
40. Ratner, B.D. Surface modification of polymers: chemical, biological and surface analytical challenges. Biosens. Bioelectron. 10, 797-804 (1995).
41. Zhang, Z. et al. Polybetaine modification of PDMS microfluidic devices to resist thrombus formation in whole blood. Lab Chip 13, 1963-1968 (2013).
42. Biological Evaluation of Medical Devices, Part 4: Selection of Tests for Interactions with Blood, 2002, Second Edition and 2006 Amendment ISO 10993-4 (Geneva, International Standards Organization, 2006).
43. Goodman, S.L. Sheep, pig, and human platelet-material interactions with model cardiovascular biomaterials. J. Biomed. Mater. Res. 45, 240-250 (1999).
44. Audran, M. et al. Determination of perfluorodecalin and perfluoro-N-methylcyclohexylpiperidine in rat blood by gas chromatography-mass spectrometry. J. Chromatogr. B Biomed. Sci. Appl. 745, 333-343 (2000).
45. Kang, J.H. et al. An extracorporeal blood cleansing device for sepsis therapy. Nat. Med. doi: 10.1038/nm.3640 (14 September 2014).